Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Dementia 1 Alzheimer Disease 1

Interventions

Cyclophosphamide 172 Rituximab 157 Specimen Handling 116 Biopsy 93 Magnetic Resonance Spectroscopy 90 Vincristine 89 Doxorubicin 83 Prednisone 81 fludarabine 70 venetoclax 67 obinutuzumab 62 ibrutinib 55 Lenalidomide 55 Dexamethasone 55 Cytarabine 49 Methotrexate 46 acalabrutinib 43 Etoposide 41 blinatumomab 40 CT-P10 39 Bendamustine Hydrochloride 37 fludarabine phosphate 33 Gemcitabine 33 prednylidene 32 Calcium Dobesilate 32 deltacortene 31 zanubrutinib 30 pembrolizumab 29 glofitamab 28 Nivolumab 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

UE2343 × Lymphoid × 90 days × Clear all

NCT06125951 2026-04-23

XanaMIA

Actinogen Medical

Phase 2/3 Active not recruiting

Alzheimer Disease, Dementia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡